Literature DB >> 10684640

Crystal structure of flavocetin-A, a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers.

K Fukuda1, H Mizuno, H Atoda, T Morita.   

Abstract

Snake venom contains a number of the hemostatically active C-type lectin-like proteins, which affect the interaction between von Willebrand factor (vWF) and the platelet glycoprotein (GP) Ib or platelet receptor to inhibit/induce platelet activation. Flavocetin-A (FL-A) is a high-molecular mass C-type lectin-like protein (149 kDa) isolated from the habu snake venom. FL-A binds with high affinity to the platelet GP Ibalpha-subunit and functions as a strong inhibitor of vWF-dependent platelet aggregation. We have determined the X-ray crystal structure of FL-A and refined to 2.5 A resolution. This is a first elucidation of a three-dimensional structure of the platelet GP Ib-binding protein. The overall structure reveals that the molecule is a novel cyclic tetramer (alphabeta)(4) made up of four alphabeta-heterodimers related by a crystallographic 4-fold symmetry. The tetramerization is mediated by an interchain disulfide bridge between cysteine residues at the C-terminus of the alpha-subunit and at the N-terminus of the beta-subunit in the neighboring alphabeta-heterodimer. The high affinity of FL-A for the platelet GP Ib alpha-subunit could be explained by a cooperative-binding action through the multiple binding sites of the tetramer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684640     DOI: 10.1021/bi992134z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Electrostatic properties of protein-protein complexes.

Authors:  Petras J Kundrotas; Emil Alexov
Journal:  Biophys J       Date:  2006-06-16       Impact factor: 4.033

Review 2.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

3.  Crystallization and preliminary X-ray crystallographic analysis of agkicetin-C from Deinagkistrodon acutus venom.

Authors:  Gufeng Xu; Qingqiu Huang; Maikun Teng; Peng Liu; Yuhui Dong; Liwen Niu
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-12-02

4.  Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.

Authors:  Piotr Jakubowski; Juan J Calvete; Johannes A Eble; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-13       Impact factor: 4.219

Review 5.  Use of snake venom inhibitors in studies of the function and tertiary structure of coagulation factors.

Authors:  Takashi Morita
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

6.  The collagen-binding integrin α2β1 is a novel interaction partner of the Trimeresurus flavoviridis venom protein flavocetin-A.

Authors:  Franziska T Arlinghaus; Johannes A Eble
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

Review 7.  The speciation of conger eel galectins by rapid adaptive evolution.

Authors:  Tomohisa Ogawa; Tsuyoshi Shirai; Clara Shionyu-Mitsuyama; Takashi Yamane; Hisao Kamiya; Koji Muramoto
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

8.  Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus).

Authors:  Kai-Fa Huang; Tzu-Ping Ko; Chin-Chun Hung; John Chu; Andrew H-J Wang; Shyh-Horng Chiou
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

9.  Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2.

Authors:  Aleksandra A Watson; Johannes A Eble; Chris A O'Callaghan
Journal:  Protein Sci       Date:  2008-06-26       Impact factor: 6.725

Review 10.  Structure and function of snake venom proteins affecting platelet plug formation.

Authors:  Taei Matsui; Jiharu Hamako; Koiti Titani
Journal:  Toxins (Basel)       Date:  2009-12-28       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.